NewAmsterdam Pharma Company N.V. (NAMS) Net margin 2022–2025
NewAmsterdam Pharma Company N.V. (NAMS) net profit margin by fiscal year — reported net income divided by reported revenue.
-902.1%FY2025 · since FY2022: -22.0% → -902.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -902.1% | -371.0 pp |
| FY2024 | -531.1% | +725.1 pp |
| FY2023 | -1256.2% | -1234.2 pp |
| FY2022 | -22.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice